Alembic Limited is an India-based company engaged in the business of development, manufacturing, and marketing of pharmaceutical products. The Company's segments include the Active Pharmaceutical Ingredients Business and the Real Estate Business. The Active Pharmaceutical Ingredients Business is engaged in the manufacturing and marketing of fermentation and chemistry-based active pharmaceutical ingredients (API). The Real Estate Business is engaged in the construction of residential and commercial real estate projects and project management and marketing consultancy. The Company provides certain commercial properties on a lease basis to various tenants. The Company is also engaged in research and development activities in Vadodara. It is also engaged in power generation through co-generation.

Employees

256

Sector

Real Estate Development & Operations

More about the company

Quotes

Date	Price	Change	Volume
26-07-03	₹92.86	-0.48%	162,004
26-07-02	₹93.31	+1.93%	416,644
26-07-01	₹91.54	-0.04%	248,321
26-06-30	₹91.58	+1.31%	206,773
26-06-29	₹90.40	-1.25%	225,942

Delayed Quote NSE India S.E.

More quotes

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - NSE India S.E. Other stock markets 07:05:07 2026-07-03 EDT			5-day change	1st Jan Change
92.86 ^INR	-0.48%		+1.44%	-8.23%

05-19	Alembic Limited Recommends Dividend for the Year Ended March 31, 2026	CI
05-19	Alembic Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Market Cap	18.21B 191M 167M 154M 143M 272M 276M 1.84B 717M 8.95B 718M 702M 30.84B	P/E 2024	8x	P/E 2025	8.14x
Enterprise Value	17.77B 187M 163M 150M 140M 265M 269M 1.8B 700M 8.73B 701M 686M 30.1B	EV / Sales 2024	13.6x	EV / Sales 2025	11.2x
Free-Float	27.79%	Yield 2024	2.87%	Yield 2025	2.44%

05-19	Alembic Limited Recommends Dividend for the Year Ended March 31, 2026	CI
05-19	Alembic Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
04-23	Alembic Pharmaceuticals Incorporates Philippines Subsidiary	MT
02-12	Alembic Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
11-27	Bajaj Healthcare Limited Appoints Shreekumar Shankarnarayan Nair as Chief Operating Officer, Effective November 27, 2025	CI
11-17	Accenture Invests in AI Marketing Intelligence Platform Alembic	MT
11-17	Alert wrongly tagged to India's Alembic withdrawn	RE
11-17	Alembic raises $145 million to accelerate enterprise adoption of causal AI	RE
11-17	Accenture invests in Alembic to reinvent marketing measurement with data and Causal AI	RE
11-10	Alembic Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
25-08-12	Alembic Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
25-08-12	Alembic Limited Announces Resignation of Malika Amin as CEO, Effective 1 January, 2026	CI
25-08-12	Alembic Limited Announces Resignation of Malika Amin as Managing Director, Effective 1 January, 2026	CI

25-07-04	Alembic : Annual Report 2024-25	PU
25-05-27	Supreme Court Rules Against Ex-Post Facto Environment Clearance	AQ
24-08-14	Alembic Pharmaceuticals announces USFDA Dabigatran Etexilate Capsules, 110 mg	AQ
24-07-25	Alembic Pharmaceuticals announces USFDA Final Approval for Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, and 10 mg	AQ
23-08-07	Alembic Pharmaceuticals - Revenue up 18% to Rs. 1486 crores in Q-1 FY24	AQ

Alembic Limited Stock NSE India S.E.

Stocks

ALEMBICLTD

INE426A01027

Real Estate Development & Operations

Valuation: Alembic Limited

Chart: Alembic Limited

Latest news : Alembic Limited

Press Releases: Alembic Limited

Quotes and Performance

Course Extremes

Managers and Directors: Alembic Limited

Other Real Estate Development & Operations

Financials

Company Profile

Quotes

Income Statement and Estimates

1 day	-0.48%
1 week	+1.44%
Current month	+1.40%
1 month	+6.31%
3 months	+19.25%
6 months	-10.17%
Current year	-8.23%

1 week	89.91	93.9
1 month	85.05	95.53
Current year	70.46	105
1 year	70.46	122.4
3 years	70.46	169
5 years	55.2	169
10 years	24.8	169

Manager	Title	Age	Since
Udit Chirayu Amin CEO	Chief Executive Officer	46	2025-09-30
Rasesh J. Shah DFI	Director of Finance/CFO	-	2014-08-12
Kevalkumar B. Thakkar CMP	Compliance Officer	-	2023-08-31

Director	Title	Age	Since
Chirayu Ramanbhai Amin CHM	Chairman	78	1967-08-19
Malika Chirayu Amin BRD	Director/Board Member	71	1988-07-01
Udit Chirayu Amin BRD	Director/Board Member	46	2013-04-23

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ALEMBIC LIMITED	-0.48%	+1.44%	-	-	252M
NFINITI INC.	+252.94%	-99.80%	-99.25%	-	95.45B
SUN HUNG KAI PROPERTIES LIMITED	+1.86%	-1.37%	+23.98%	+16.82%	41.83B
MITSUBISHI ESTATE CO., LTD.	+3.08%	+5.80%	+51.89%	+146.49%	30.66B
EMAAR PROPERTIES	+1.51%	-0.66%	-9.89%	+89.08%	28.73B
CHINA RESOURCES LAND LIMITED	+0.19%	+2.91%	+16.12%	-6.27%	28.24B
MITSUI FUDOSAN CO., LTD.	+1.85%	+4.41%	+8.34%	+61.51%	25.54B
ALPHA DHABI HOLDING	+4.31%	+1.99%	-33.92%	-60.71%	21.45B
SUMITOMO REALTY & DEVELOPMENT CO., LTD.	+3.16%	+10.13%	+35.96%	+116.55%	21.41B
CK ASSET HOLDINGS LIMITED	-0.05%	-0.76%	+25.62%	+2.03%	19.77B
Average	+26.84%	+0.76%	+2.09%	+45.69%	34.79B
Weighted average by Cap.	+78.42%	+0.40%	-19.00%	+47.70%

	2024	2025
Net sales	1.57B 16.54M 14.46M 13.29M 12.39M 23.49M 23.85M 160M 62.02M 774M 62.09M 60.75M 2.67B	2.22B 23.3M 20.37M 18.72M 17.45M 33.1M 33.6M 225M 87.38M 1.09B 87.47M 85.6M 3.76B
Net income	2.69B 28.21M 24.66M 22.67M 21.13M 40.07M 40.68M 272M 106M 1.32B 106M 104M 4.55B	3.11B 32.63M 28.52M 26.21M 24.43M 46.35M 47.05M 315M 122M 1.53B 122M 120M 5.26B
Net Debt	-37.08M -389K -340K -313K -292K -553K -562K -3.76M -1.46M -18.23M -1.46M -1.43M -62.81M	-438M -4.6M -4.02M -3.7M -3.45M -6.54M -6.64M -44.39M -17.26M -215M -17.28M -16.91M -742M